[The CORONA study]

G Ital Cardiol (Rome). 2008 Apr;9(4):229-33.

[Article in Italian]

Authors

Marco Metra¹, Valerio Zacá, Savina Nodari, Livio Dei Cas, Aldo P Maggioni

Affiliation

¹ Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale ed Applicata, Universitá degli Studi, Brescia. [email protected]

PMID: 18543792

No abstract available

MeSH terms

Age Factors
Aged
Aged, 80 and over
Cholesterol, LDL / blood
Fluorobenzenes / administration & dosage
Fluorobenzenes / therapeutic use*
Follow-Up Studies
Heart Failure, Systolic / blood
Heart Failure, Systolic / drug therapy*
Heart Failure, Systolic / mortality
Hospitalization
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Middle Aged
Prospective Studies
Pyrimidines / administration & dosage
Pyrimidines / therapeutic use*
Randomized Controlled Trials as Topic
Risk Factors
Rosuvastatin Calcium
Sulfonamides / administration & dosage
Sulfonamides / therapeutic use*
Time Factors
Treatment Outcome

Substances

Cholesterol, LDL
Fluorobenzenes
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pyrimidines
Sulfonamides
Rosuvastatin Calcium